Navigation Links
Probiotic Action Announces Probiotics Pending Listing on EU Foods
Date:3/21/2013

Miami, FL (PRWEB) March 21, 2013

Last week an article from a leading UK food manufacture news site shared news that Monday March 18th a European Commision group would sit to discuss whether or not the term “Probiotic” will be approved as a legal general description on food labels. The UK’s Department of Health, (DH) held the commission which discussed many other food description labels during the meeting. Yogurt manufacturers and probiotic suppliers, along with lobbyist groups like the Yogurt and Live Fermented Milk Association have past lobbied to have the UK’s DH continue to allow the listing of probiotics as a general listing, due to the increased health benefits of probiotics in food. The DH has been questioning the validity of listing probiotics as an approved health benefit in food regardless of numerous reports of the germs aiding a consumers health for years.

Probiotic Action spokesman Fernando Perez explains the controversy on listing probiotics, “ Even in the United States, probiotics are not FDA approved. While the FDA can not totally regulate a live an active culture, institutions like the FDA and other government associations like the UK’s HD recognize the history probiotics have in promoting good health. They are weary of listing of ‘Probiotics’ because they do not want to commit to the health benefits, or allow companies to make false health benefit claims if their added ‘probiotics’ have not been tested.”

Probiotic Action also reports that in lieu of the pending approval, many manufacturers have taken the term ‘probiotic’ off of their labels. On the subject of the terms’ legality Dr. Julian Stowel stated in the article that there are well beyond 70 different claims associated wit
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Probiotic Action shares Insight on New Ways to Take Probiotics
2. Probiotic Action Announces China’s $5 Billion Dollar Investment in Probiotics
3. Probiotic Action Explains New Research that Probiotics Help Reduce Stress Side Effects
4. Probiotic Action Announces Probiotics Lead the Digestive Health Market
5. DistinctBright, Probiotic Cleaner, Announces their Probiotic Cleaner is Safe for Pets
6. DistinctBright Shares New Tips on How to Clean Pandora Bracelets with their Probiotic Cleaner
7. China Probiotics Market 2012-2016
8. New Strain of Bacteria May Clear up Acne Probiotic Action Explains the New Research Findings from Washington University
9. Probiotic Action Explains New Study from the Utah State University on how Probiotics May Help Weight Loss
10. New Research Shows Probiotics are good for more than just Digestive and Skin Care Health, Probiotic Action Explains the News
11. New Research Suggests Probiotics May Lower Cholesterol, Probiotic Action Reports with Insight from the New York Times
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... Calif. , July 1, 2015   ... on the development of groundbreaking drugs to treat ... announced today that Robert G. Miller , ... at Sutter Health,s California Pacific Medical Center in San ... ALS Association for $1.5 million to help fund ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... Apex Therapeutics ... BIO International Convention in Philadelphia, PA. , The presentation took place on ... outlined the plans for the development of APX3330 for the treatment of pancreatic cancer. ...
(Date:6/30/2015)... - Resverlogix Corp. ("Resverlogix") (TSX:RVX) announced today that ... approved the resolutions relating to: (i) a private ... at a price of $2.67 per unit (the ... one common share and 0.075358 common share purchase ... and (ii) the amendment to Resverlogix,s articles to ...
(Date:6/30/2015)... ... 30, 2015 , ... uBiome and OpenBiome Partner for Microbiome ... fecal microbiota transplantation in C. difficile patients. , SAN FRANCISCO, uBiome and OpenBiome ... microbiota transplantation (FMT) as a treatment for Clostridium difficile infections (C. diff). , ...
Breaking Biology Technology:Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4Apex Therapeutics Presented Company Overview at This Year’s BIO International Convention in Philadelphia, PA 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 3uBiome and OpenBiome Partner for Microbiome Study in FMT Patients 2uBiome and OpenBiome Partner for Microbiome Study in FMT Patients 3
... 24 United Therapeutics Corporation (Nasdaq: UTHR ... first quarter financial results before market open on Friday, ... on Friday, May 1, 2009, at 9:00 a.m. Eastern ... with international callers dialing 719-325-4795. A rebroadcast of ...
... plays a key role in determining risk for colorectal ... the United States. Several common genetic markers have ... finding the biological events that lead to cancer can ... online in Genome Research (www.genome.org), scientists have ...
... ULURU Inc. (NYSE Amex: ULU ) ... wounds using Altrazeal(TM) along with pre-clinical and physical data on ... Society for Advance Wound Care Conference ("SAWC") being held in ... data will be presented on posters on display during the ...
Cached Biology Technology:Beyond associations: Colorectal cancer culprit found 2ULURU to Present Clinical Evidence and Advanced Research on Altrazeal at the Society for Advance Wound Care Conference for 2009 2
(Date:6/23/2015)... Fla. , June 23, 2015 /PRNewswire/ ... management and authentication solutions, today announced enhanced functionality ... multi-factor authentication solution.  The enhancements build on ... of the DigitalPersona Altus platform and provide ... compatibility. In today,s environment of ...
(Date:6/18/2015)... , June 18, 2015 NXT-ID, Inc. (NASDAQ: ... focused on the growing mobile commerce market announces that its ... segment on "Money on the Mark", scheduled to air on ... June 20 th . The broadcast ... from 7:00 to 8:00pm EST. NXT-ID, Inc.,s CEO Gino ...
(Date:6/17/2015)... Germany , June 17, 2015 ... Standard: QIA) today launched new Investigator ® STR assay ... the United States . The new genetic ... key genomic markers (short tandem repeats or STRs) for DNA ... evaluate the quality of DNA in each sample, a novel ...
Breaking Biology News(10 mins):Crossmatch Releases Enhanced DigitalPersona Altus Advanced Authentication Functionality 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 4QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 5
... (Cincinnati, OH) In a study published today in the ... an international team of researchers based in the U.S. and ... lethal, breath holding episodes associated with the neurological disease Rett ... that affects around 1 in 10,000 young girls. On October ...
... Institute in Boston have identified a new type of cell ... animal,s own cells from immune system attack. This ... drive lupus and other autoimmune diseases in which the immune ... The discovery, published in the September 16 issue of ...
... October 4, 2010 Onconova Therapeutics, Inc. announced ... regarding a Special Protocol Assessment (SPA) for the design ... 01910.Na) as monotherapy in patients with myelodysplastic syndromes (MDS), ... the bone marrow. The SPA provides FDA evaluation and ...
Cached Biology News:Research breakthrough hailed on the anniversary of gene discovery 2Discovery of a cell that suppresses the immune system 2Onconova announces FDA agreement of a SPA for a pivotal phase 3 trial of Estybon in MDS 2